Antibiotic resistance is an urgent issue of global concern, and this growing epidemic is directly related to the level of antibiotic use. A key contributing factor to antibiotic misuse in patients with wounds is diagnostic uncertainty, i.e. is there a bacterial infection in this wound? At the recent EWMA and Wounds Canada Kamloops meetings, Rosemary Hill, BSN CWOCN CETN(C) summarized how bacterial fluorescence imaging with the MolecuLight i:X has improved her antimicrobial stewardship capabilities in a series of patients with diverse wounds.
MolecuLight images prevented unwarranted use of antibiotics and also demonstrated the need for antibiotics in several asymptomatic patients who were about to be discharged from hospital. Rosemary Hill concluded that “Real-time, point-of-care bacterial fluorescence images facilitated evidence-based deployment of systemic antibiotics and also prevented their unnecessary use. This case series highlights the potential of this handheld imaging device to provide invaluable, real-time information regarding the pathogenic state of a wound that can guide appropriate use of antibiotics and facilitate antimicrobial stewardship.”